USE FOR GLYCOLIPOPROTEIN GINTONIN, ISOLATED AND IDENTIFIED FROM GINSENG, AS A NATURAL MEDICINAL-PLANT-DERIVED LIGAND
    1.
    发明申请
    USE FOR GLYCOLIPOPROTEIN GINTONIN, ISOLATED AND IDENTIFIED FROM GINSENG, AS A NATURAL MEDICINAL-PLANT-DERIVED LIGAND 审中-公开
    使用甘油磷酸甘油,作为天然药物衍生的配子从金山分离鉴定

    公开(公告)号:WO2013042943A3

    公开(公告)日:2013-07-11

    申请号:PCT/KR2012007505

    申请日:2012-09-19

    摘要: The present invention relates to glycolipoprotein gintonin, isolated and identified from ginseng, as a natural medicinal-plant-derived ligand acting on LPA1(lysophosphatidic acid; 1- or 2-acyl-sn-glycerol-3-phosphate), LPA2, LPA3, LPA4 and LPA5 receptors whose efficacy is exhibited physiologically/pharmaceutically via an interaction with subset receptors [LPA1(edg-2), LPA2(edg-4), LPA3(edg-7), LPA4, PLA5] in the EDG (endothelial differentiation gene) family in G protein-coupled receptors (GPCRs) present in the cell membranes of animals including humans. The gintonin of the present invention can be used to advantage in the prevention and treatment of various diseases arising from reduced calcium concentration and various physiological activities and pharmaceutical activities dependent on calcium, since the gintonin of the present invention interacts with LPA receptors so as to activate a series of signal transmission processes and temporarily induce an increase in free Ca2+ in the cytoplasm, and a temporary increase in the intracellular calcium concentration gives rise to a temporary increase in the intracellular calcium concentration in various organs including, inter alia, those of the nervous system, cardiovascular system, endocrine system, reproductive system, digestive system and immune system where the LPA receptors are expressed, with physiological activity being exhibited.

    摘要翻译: 本发明涉及从人参中分离和鉴定的作为天然药用植物衍生的配体作用于LPA1(溶血磷脂酸; 1-或2-酰基-sn-甘油-3-磷酸),LPA2,LPA3, LPA4和LPA5受体,其功效在EDG(内皮分化基因)中与子集受体[LPA1(edg-2),LPA2(edg-4),LPA3(edg-7),LPA4,PLA5) )家族存在于动物包括人类的细胞膜中的G蛋白偶联受体(GPCR)中。 本发明的甜菜素可以有利地用于预防和治疗由于钙浓度降低和各种生理活性以及依赖于钙的药物活性而引起的各种疾病,因为本发明的甜菜素与LPA受体相互作用以激活 一系列信号传导过程并暂时诱导细胞质中游离Ca 2+的增加,并且细胞内钙浓度的暂时增加导致各种器官中的细胞内钙浓度的暂时增加,包括特别是神经元 系统,心血管系统,内分泌系统,生殖系统,消化系统和表达LPA受体的免疫系统,并显示生理活性。

    WRITE-ONCE DISC, METHOD OF USING WRITE-ONCE DISC, AND DATA RECORDING AND/OR REPRODUCING APPARATUS
    5.
    发明申请
    WRITE-ONCE DISC, METHOD OF USING WRITE-ONCE DISC, AND DATA RECORDING AND/OR REPRODUCING APPARATUS 审中-公开
    写入光盘,使用写入光盘的方法和数据记录和/或复制设备

    公开(公告)号:WO2005031741A1

    公开(公告)日:2005-04-07

    申请号:PCT/KR2004/002479

    申请日:2004-09-24

    IPC分类号: G11B20/12

    摘要: Provided are a write-once disc, a method of using the write-once disc, and a data recording and/or reproducing apparatus. The method includes: allocating at least one spare area to a data area of the recording layers; and dividing each spare area into a sub spare area and a temporary disc management area in the direction in which user data is recorded. Here, the size of the temporary disc management area is greater than or equal to 1/N (N is a real number) of the size of one spare area.

    摘要翻译: 提供了一次写入盘,使用一次写入盘的方法以及数据记录和/或再现装置。 该方法包括:向记录层的数据区分配至少一个备用区; 并将每个备用区划分成用户数据记录方向的子备用区和临时盘管理区。 这里,临时盘管理区域的大小大于或等于一个备用区域的大小的1 / N(N是实数)。

    METHOD AND APPARATUS FOR MANAGING DISC DEFECT AND DISC THEREFOR
    6.
    发明申请
    METHOD AND APPARATUS FOR MANAGING DISC DEFECT AND DISC THEREFOR 审中-公开
    用于管理椎间盘缺损和椎间盘的方法和装置

    公开(公告)号:WO2004079730A1

    公开(公告)日:2004-09-16

    申请号:PCT/KR2004/000419

    申请日:2004-02-27

    IPC分类号: G11B7/007

    摘要: A write once disc includes a defect management area that is present in at least one of a lead-in area and a lead-out area; a temporary defect management area that is present in at least one of the lead-in area and the lead-out area; and a drive & disc information area that is present in at least one of the lead-in area and the lead-out area. Information regarding the locations of temporary defect information and temporary defect management information is recorded in the drive & disc information area, the temporary defect information and temporary defect management information, which includes drive & disc information, are recorded in the temporary defect management area, and temporary defect information and temporary defect management information, which are lastly recorded in the temporary defect management area, are recorded in the defect management area for disc finalization.

    摘要翻译: 一次写入盘包括存在于导入区域和导出区域中的至少一个中的缺陷管理区域; 存在于导入区域和导出区域中的至少一个中的临时缺陷管理区域; 以及存在于导入区域和导出区域中的至少一个中的驱动器和盘片信息区域。 关于临时缺陷信息和临时缺陷管理信息的位置的信息被记录在驱动盘信息区域中,包括驱动盘信息的临时缺陷信息和临时缺陷管理信息被记录在临时缺陷管理区域中,以及 最后记录在临时缺陷管理区域中的临时缺陷信息和临时缺陷管理信息被记录在用于盘完成的缺陷管理区域中。

    APPARATUS AND METHOD FOR SUPPORTING VARIABLE LENGTH OF TRANSPORT PACKET IN VIDEO AND AUDIO COMMUNICATION SYSTEM
    7.
    发明申请
    APPARATUS AND METHOD FOR SUPPORTING VARIABLE LENGTH OF TRANSPORT PACKET IN VIDEO AND AUDIO COMMUNICATION SYSTEM 审中-公开
    在视频和音频通信系统中支持运输包的可变长度的装置和方法

    公开(公告)号:WO2012093846A2

    公开(公告)日:2012-07-12

    申请号:PCT/KR2012000074

    申请日:2012-01-04

    IPC分类号: H04L12/56 H04N21/23

    摘要: Methods and apparatus are provided for supporting a variable-length transport packet in an Audio/Video (AV) communication system. Data to be transmitted is determined. It is determined whether a transport packet is the variable-length transport packet. A header having information indicating whether the transport packet is the variable-length transport packet is generated. When the transport packet is the variable-length transport packet, an optional header having length information of the transport packet is generated, and the data and the transport packet having the header and the optional header, are transmitted. When the transport packet is not the variable-length transport packet, the determined data and the transport packet having the header are transmitted.

    摘要翻译: 提供了用于在音频/视频(AV)通信系统中支持可变长度传输分组的方法和装置。 要发送的数据被确定。 确定传输分组是否是可变长度传输分组。 产生具有指示传输分组是否是可变长度传输分组的信息的报头。 当传输分组是可变长度传输分组时,生成具有传输分组的长度信息的可选报头,并且发送具有报头和可选报头的数据和传输分组。 当传输分组不是可变长度传输分组时,发送所确定的数据和具有报头的传输分组。